FDA manufacturing GMP documents
FDA plans to issue final quality systems guidance by summer, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb says March 14 at the International GMP Conference in Athens, Ga. The September 2004 draft guidance, which was part of FDA's final report on its Pharmaceutical cGMP Initiative for the 21st Century, calls for regular analysis of trends in batch quality (1"The Pink Sheet" Oct. 4, 2004, p. 20). FDA also plans to complete a report summarizing "the work of our risk management work group, which was charged with identifying continuous improvements in the risk model for prioritizing sites for manufacturing inspections," Gottlieb adds...
You may also be interested in...
A quality systems approach to manufacturing should include continual monitoring and analysis of trends in batch quality, FDA's quality systems draft guidance states
The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.
The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.